Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: Suggestions for HPV vaccination policies

Vaccine

Volumn 27, Issue SUPPL. 1, 2009, Pages

  Panatto, Donatella ^a   Amicizia, Daniela ^a   Lugarini, Jessica ^a   Sasso, Tiziana ^a   Sormani, Maria Pia ^a   Badolati, Giuseppe ^a   Gasparini, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Human papillomavirus; Sexual behaviour; Vaccination policies

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CHILD; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; ITALY; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADOLESCENT BEHAVIOR; FEMALE; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; ITALY; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; SEXUAL BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 65749113398     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.057     Document Type: Article

References (30)

1. Trottier H., and Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 24 Suppl. 1 (2006) S4-S15
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
3. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of worldwide mortality from 25 cancers in 1990. Int J Cancer 83 December (6) (1999) 870-873
4. Parkin D.M., and Bray F. The burden of HPV-related cancers, Chapter 2. Vaccine 24 August (Suppl. 3) (2006) S11-25
5. AIRT Working Group. I tumori in Italia-Rapporto 2006. Incidenza, mortalità e stime. Epidemiologia e prevenzione; 2006. http://www.registri-tumori.it/cms/?q=Rapp2006 [28 August 2008].
6. Ronco G., Ghisetti V., Segnan N., Snijders J.F.P., Gillio-Tos A., Meijer C.J., et al. Prevalence of human papillomavirus infection in women in Turin Italy. Eur J Cancer 41 2 (2005) 297-305
7. Munoz N., Bosch F.X., Castellsague X., Diaz M., de Sanjose S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 (2004) 278-285
8. Meeting of the immunization Strategic Advisory Group of Experts, Graz, April 2007-conclusions and recommendations. Wkly Epidemiol Rec 2007;82(May (21)):181-93.
9. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51:1-78.
10. Comunicato Ministero della Salute n. 34 del 9 Febbraio 2007. Turco L.: l'Italia sarà il primo Paese europeo a vaccinare gratuitamente le giovani donne. Vaccino HPV contro cancro cervice uterina. www.ministerosalute.it [20 February 2007].
11. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(May (RR-6)):1-78.
12. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 297 8 (2007) 813-819
13. Burchell A.N., Winer R.L., de Sanjosè S., and Franco E.L. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 24 Suppl. 3 (2006) S52-S61
14. Sellors J.W., Karwalajtys T.L., Kaczorowski J., Mahony J.B., Lytwyn A., Chong S., et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 168 4 (2003) 421-425
15. Renzi C., Signorelli C., Zantedeschi E., and Fara G.M. A possible "marker" for subsequent high risk sexual behaviour in young Italians. J Prev Med Hyg 42 (2001) 1-14
16. Signorelli C., and Colzani E. Age at first intercourse and HPV immunization. J Prev Med Hyg 48 2 (2007) 37-38
17. Signorelli C., Pasquarella C., Limina R.M., Colzani E., Fanti M., Cielo A., et al. Third Italian national survey on knowledge, attitudes, and sexual behaviour in relation to HIV/AIDS risk and the role of health education campaigns. Eur J Public Health 16 5 (2006) 498-504
18. Kraft P. Age of first intercourse among Norvegian adolescent: a lifetime perspective. Soc Sci Med 2 (1991) 207-213
19. Johnson A.M., Wadsworth J., Wellings K., and Field J. Sexual attitudes and lifestyles (1994), Blackwell Scientific Press, Oxford
20. Wellings K., Field J., Johnson A.M., and Wadsworth J. Sexual behaviour in Britain (1994), Penguin, London
21. Llavs I., Rodrigues L.C., Weiss H.A., and Hayes R. Factors associated with early sexual debut in Slovenia: result of a general population survey. Sex Transm Infect 82 (2006) 478-483
22. Lewin B. The adolescent boy and girl: first and other early experience with intercourse from a representative sample of Swedish school adolescents. Arch Sex Behav 11 (1982) 417-429
23. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 (2005) 271-278
24. Harper D.H., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
25. French K.M., Barnabas R.V., Lehtinen M., Kontula O., Pukkala E., Dillner J., et al. Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer 96 (2007) 514-518
26. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., and Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 February (3) (2003) 218-226 [Erratum in: Am J Epidemiol 2003;157(May (9)):858]
27. Winer R.L., Feng O., Hughes J.P., O' Reilly S., Kiviat N.B., and Koutsky L.A. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 197 (2008) 279-282
28. Collins S., Mazloomzadeh S., Winter H., Blomfield P., Bailey A., Young L.S., et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. Br J Obstet Gynaecol 109 1 (2002) 96-98
29. Ault K.A., and Future II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369 June (9576) (2007) 1861-1868
30. Block S.L., Nolan T., Sattler C., Barr E., Giacoletti K.E.D., Marchant C.D., et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 118 November (5) (2006) 2135-2145